Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > 1/2 million shares asking 19¢ since January 7 or before-WTF?
View:
Post by ChupacabraBueno on Jan 15, 2021 10:01am

1/2 million shares asking 19¢ since January 7 or before-WTF?

What are they up to? You would think that if they relly wanted to sell at that price they would be getting impatient after more than 1 week.
Comment by Pandora on Jan 15, 2021 10:36am
And it shows just how enthusiastic people are about buying in -- can't quite get up the courage to pay 19 cents. Maybe it has something to do with te flow of information (or not) from the company on just what might be happening.
Comment by robertshaw on Jan 15, 2021 10:39am
It's Blowjobjoe's bosses' fake asking, but as many long investors claimed last year to buy more shares through their TFSA account at the current price , we see less action... Otherwise, we would have seen 0.17 these days
Comment by ChupacabraBueno on Jan 15, 2021 12:08pm
We did see 0.17 on Wednesday Jan 13, but only briefly. If they persist with the big ask @ 19¢ we could see 17¢ again as patient buyers have been rewarded by waiting for the price to come down to meet their low bids. My expectation is that the 19¢ ask shareholder is accumulating shares at lower prices knowing that few if any of their 19¢ shares are likely to get bought. If some ...more  
Comment by StevenBirch on Jan 15, 2021 12:12pm
Wouldn't it be nice if we could start eating into that $0.19 offering? I see someone has joined that offering buit would they run it started trading there?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250